It has been suggested that TLR2 is upregulated in the pathogenesis of synucleinopathies in the brains of PD patients, thereby establishing TLR2 as a mediator of not only pro-inflammatory but also neurotoxic effects of extracellular α-synuclein aggregates. Here, TLR2 is linked to synucleinopathy.